Home/Filings/4/0001104659-23-125200
4//SEC Filing

WG Biotech ApS 4

Accession 0001104659-23-125200

CIK 0001722964other

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 8:27 AM ET

Size

5.8 KB

Accession

0001104659-23-125200

Insider Transaction Report

Form 4
Period: 2023-12-11
WG Biotech ApS
Director10% Owner
Transactions
  • Purchase

    Common stock

    2023-12-11$6.85/sh+6,455$44,2324,559,233 total
Footnotes (1)
  • [F1]This transaction was executed in multiple trades each at price of $6.85 to 6.86. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

Y-mAbs Therapeutics, Inc.

CIK 0001722964

Entity typeother
IncorporatedDenmark

Related Parties

1
  • filerCIK 0001753193

Filing Metadata

Form type
4
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 8:27 AM ET
Size
5.8 KB